Literature DB >> 112482

Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.

H G Joost, A Hasselblatt.   

Abstract

Glibenclamide, a "second generation" sulfonylurea, produced the same pattern of insulin release from the perfused rat pancreas as did tolbutamide. The stimulatory effect was closely dependent on the glucose concentration present. Both agents enhanced insulin secretion at 5--10 mM glucose, whereas no additional insulin was released when maximally stimulating levels of glucose (20 and 30 mM) were present. The concentrations of glibenclamide stimulating insulin release were 100--400 times lower than equieffective levels of tolbutamide. At glucose levels of 3 or 8 mM, however, glibenclamide did not liberate significantly more insulin from the pancreas than did tolbutamide. Thus the differences of tolbutamide and glibenclamide were quantitative rather than qualitative. Although the active concentrations differed the effects produced were comparable.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112482     DOI: 10.1007/bf00507101

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  EFFECTS OF CARBOHYDRATES ON SECRETION OF INSULIN FROM ISOLATED RAT PANCREAS.

Authors:  G M GRODSKY; A A BATTS; L L BENNETT; C VCELLA; N B MCWILLIAMS; D F SMITH
Journal:  Am J Physiol       Date:  1963-10

2.  [Insulin secretion as studied on isolated perfused rat pancreas. I. Synergism between glucose and hypoglycaemic sulphonamides].

Authors:  A Loubatières; M M Mariani; J Chapal
Journal:  Diabetologia       Date:  1970-10       Impact factor: 10.122

3.  [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors:  H Mehnert; E Karg
Journal:  Dtsch Med Wochenschr       Date:  1969-04-18       Impact factor: 0.628

4.  Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells.

Authors:  B Hellman
Journal:  Metabolism       Date:  1974-09       Impact factor: 8.694

5.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

6.  [A new highly-active oral antidiabetic].

Authors:  W Aumüller; A Bänder; R Heerdt; K Muth; W Pfaff; F H Schmidt; H Weber; R Weyer
Journal:  Arzneimittelforschung       Date:  1966-12

7.  Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion.

Authors:  J C Basabe; J M Farina; R A Chieri
Journal:  Horm Metab Res       Date:  1976-11       Impact factor: 2.936

8.  Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran).

Authors:  H G Joost; J Beckmann; S Holze; S Lenzen; W Poser; A Hasselblatt
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

9.  Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.

Authors:  R S Bosboom; J Zweens; P R Bouman
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

  9 in total
  1 in total

1.  Tolbutamide potentiates the volume-regulated anion channel current in rat pancreatic beta cells.

Authors:  L Best; S Davies; P D Brown
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.